Drug or chemical induced diabetes mellitus with other specified complications
ICD-10 E09.6 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with other specified complications.
Drug or chemical induced diabetes mellitus (E09) refers to diabetes that arises as a result of the administration of certain medications or exposure to specific chemicals. This condition can manifest in patients who are receiving treatments such as glucocorticoids, antipsychotics, or other drugs known to affect glucose metabolism. The 'with other specified complications' designation indicates that the patient may experience additional complications related to diabetes, such as neuropathy, retinopathy, or cardiovascular issues. Management of drug-induced diabetes often requires careful monitoring of blood glucose levels, with an emphasis on maintaining HbA1c levels below 7% to reduce the risk of complications. Insulin therapy may be necessary, especially in cases where oral hypoglycemic agents are ineffective. It is crucial for healthcare providers to document the specific drug or chemical responsible for the diabetes, as well as any complications that arise, to ensure accurate coding and appropriate management.
Detailed medication history, HbA1c levels, and complications must be documented.
Patients on glucocorticoids for autoimmune diseases developing diabetes.
Endocrinologists must ensure that the cause of diabetes is clearly linked to medication.
Document the psychiatric medications prescribed and their potential impact on glucose metabolism.
Patients on atypical antipsychotics developing diabetes.
Psychiatrists should monitor metabolic side effects of medications closely.
Used for follow-up visits for management of drug-induced diabetes.
Document the patient's medication history, HbA1c levels, and any complications.
Endocrinologists should focus on metabolic control and medication adjustments.
Common drugs that can induce diabetes include glucocorticoids, certain antipsychotics, and some antihypertensives. It is essential to document the specific drug responsible for accurate coding.
